Clinical Trials Logo

Coat's Disease clinical trials

View clinical trials related to Coat's Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT00211315 Completed - Coat's Disease Clinical Trials

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

Start date: March 2002
Phase: Phase 2
Study type: Interventional

Congenital Telangiectasia or Coat's disease is an uncommon disorder that involves the growth of blood vessels of the macula. These blood vessels msy extend beneth the retina to produce an area of sub-retinal neovascularization(growth of abnormal blood vessels under the retina which "leak" fluid, causing reduction in vision). Limited forms of treatment are available in managing the neovascularization and its consequences. Anecortave Acetate injection will be considered as an attempt to control the growth of the abnormal blood vessels.